What is the appropriate treatment for epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Epistaxis

For active epistaxis, immediately lean forward and apply firm nasal compression to the soft part of the nose for at least 5 minutes, extending to 15 minutes if bleeding slows; if this fails, use topical vasoconstrictors (oxymetazoline or phenylephrine) after clearing clots, followed by nasal packing if bleeding persists. 1, 2

Initial Management Algorithm

First-Line Treatment (Home or Clinical Setting)

Patient positioning and direct compression:

  • Lean forward (not backward) to prevent blood from entering the throat
  • Pinch the soft cartilaginous part of the nose firmly for a minimum of 5 minutes
  • If bleeding slows, continue compression for a full 15 minutes 1
  • This approach controls 65-75% of nosebleeds presenting to emergency settings 3

Topical vasoconstrictors (if compression alone fails):

  • First blow the nose to clear any clots
  • Apply oxymetazoline or phenylephrine spray (2 sprays to the bleeding nostril)
  • Continue holding the soft part of the nose for 5 minutes
  • May repeat once if needed 1

Second-Line Treatment (Clinical Setting Required)

Anterior rhinoscopy to identify bleeding site:

  • Remove any blood clots present
  • Visualize the bleeding source to guide further treatment 2
  • 95% of epistaxis is anterior in location 4

Cauterization (when bleeding site is identified):

  • Anesthetize the bleeding site first
  • Apply cautery only to the active or suspected bleeding site(s)
  • Chemical cauterization with silver nitrate is effective but electrical cautery has fewer recurrences (14.5% vs 35.1%) 3, 5
  • Tranexamic acid (1000 mg topically) achieves hemostasis in 78% of patients versus 35% with oxymetazoline alone, with 4.3 times less rebleeding 6, 3

Third-Line Treatment (Persistent Bleeding)

Nasal packing:

  • Use when bleeding precludes identification of the bleeding site despite nasal compression 2
  • For patients on anticoagulation/antiplatelet medications or with bleeding disorders, use resorbable packing materials (e.g., Nasopore, Surgicel, Floseal, gelatin sponge) 2
  • For other patients, options include non-resorbable materials (Merocel, Rapid-Rhino balloons) or resorbable materials 3
  • Apply vasoconstrictor spray (oxymetazoline) to the packing material (used in 40.34% of cases) 4
  • Inflatable anterior nasal balloon packs reliably control most nosebleeds 5

Patient education for nasal packing:

  • Inform about the type of packing placed
  • Timing and plan for removal (if non-resorbable)
  • Post-procedure care instructions
  • Signs/symptoms requiring prompt reassessment 2

Fourth-Line Treatment (Refractory Cases)

Nasal endoscopy:

  • Perform when bleeding precludes identification despite nasal compression
  • Examine nasal cavity and nasopharynx for unrecognized pathology
  • Essential for recurrent bleeding despite prior packing or cautery 2

For posterior epistaxis (5% of cases):

  • Add Foley catheter nasopharyngeal balloon pack for posterior bleeding 5
  • Consider early surgical intervention: endoscopic sphenopalatine artery (SPA) ligation is more effective than conventional packing (97% vs 62% success) 3, 7
  • Endoscopic cauterization is more effective than ligation alone 3

Arterial embolization:

  • Reserved for intractable cases or high-risk surgical candidates
  • 80% success rate with comparable efficacy to surgical methods
  • Uses gelatin sponge, foam, PVA particles, or coils 3, 7

Critical Management Principles for Anticoagulated Patients

Do not routinely discontinue anticoagulation/antiplatelet medications:

  • Initiate first-line treatments prior to transfusion, reversal of anticoagulation, or withdrawal of these medications (in absence of life-threatening bleeding) 2
  • These medications treat serious medical conditions
  • Promptly contact the prescribing clinician
  • If bleeding is severe, hold additional doses until evaluated, but do not delay evaluation 1

Prevention and Post-Treatment Care

Preventive measures:

  • Eliminate digital trauma (nose picking) and vigorous nose blowing
  • Use nasal saline gel or spray 1-3 times daily for moisturization
  • Apply humidifier at bedside 1

Post-cauterization restrictions (minimum 1 week):

  • Avoid nose blowing
  • No strenuous activity or heavy lifting
  • Do not place cotton or tissues in the nose
  • Use saline gel/spray 1-3 times daily for lubrication 1

When to Escalate Care

Seek immediate emergency care if:

  • Bleeding does not stop despite above methods
  • Bleeding is severe or persistent
  • Patient feels weak or lightheaded
  • Call 911 for severe symptoms 1

Follow-Up Requirements

Document outcomes within 30 days for patients treated with:

  • Non-resorbable packing
  • Surgery
  • Arterial ligation/embolization
  • Or document transition of care 1, 2

Common Pitfalls

  • Avoid bilateral cauterization of the septum to prevent perforation
  • Do not apply cautery beyond the active bleeding site to minimize tissue damage 2
  • Resorbable packing is mandatory for anticoagulated patients to reduce rebleeding risk during pack removal 2
  • Most epistaxis (80%) is idiopathic, but hypertension is present in 39% of cases—this is an association, not necessarily causation 4

References

Guideline

clinical practice guideline: nosebleed (epistaxis).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Guideline

clinical practice guideline: nosebleed (epistaxis) executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Research

Simplified management of epistaxis.

Journal of the American Association of Nurse Practitioners, 2021

Research

Posterior epistaxis management: review of the literature and proposed guidelines of the hellenic rhinological-facial plastic surgery society.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.